Delivery Order SPE2DE24D0013-SPE2D625F3EGY
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, has been awarded a delivery order valued at $2,040 under contract XPRS4PLEX-10 by the Medical Supply Chain, a defense-focused federal agency. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California, and represents a continuation of Cepheid's ongoing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $10.2K delivery order (Contract No. 4569067497) by the Defense Logistics Agency's Medical Supply Chain division on August 12, 2025, with a completion date of August 19, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts. Performance will take place...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,760 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025, with an ultimate completion date of August 27, 2025. This contract carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, which enable the company to provide molecular diagnostic...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3EGYDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,104 on September 11, 2025, with an ultimate completion date of September 18, 2025. The contract, designated XPRSTREPA-10, was issued by the Medical Supply Chain division of the Defense Logistics Agency with no set-aside designation. The place of performance is Sunnyvale, California, and the low contract value suggests this represents a specific purchase or task order for diagnostic equipment, reagents, or related supplies to support federal healthcare operations. This delivery order is likely issued under one of Cepheid's larger Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which include a $32.8M single-award IDV with VA's Veterans Integrated Service Network 6 (covering molecular diagnostic testing system reagents through September 30, 2030) and a $2.5M IDV with VA's Veterans Integrated Service Network 21 (focused on PCR testing for laboratory microbiology). Cepheid's federal work emphasizes rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, RSV, and tuberculosis, providing diagnostic equipment and associated reagents and maintenance services across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/11/25 |